与干扰素β-1a（Rebif）相关的多发性硬化症中的抑郁症。 - Suppr

Suppr

超能文献

Depression in multiple sclerosis associated with interferon beta-1a (Rebif).

作者信息

Pandya Rupang, Patten Scott

出版信息

Can J Psychiatry. 2002 Sep;47(7):686. doi: 10.1177/070674370204700720.

DOI:10.1177/070674370204700720

PMID:12355685

Abstract

摘要

相似文献

Depression in multiple sclerosis associated with interferon beta-1a (Rebif).与干扰素β-1a（Rebif）相关的多发性硬化症中的抑郁症。

Can J Psychiatry. 2002 Sep;47(7):686. doi: 10.1177/070674370204700720.

[Interferons beta in patients with multiple sclerosis].[多发性硬化症患者中的β干扰素]

Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(7):54-5.

Haematological effects of interferon-beta-1a (Rebif) therapy in multiple sclerosis.干扰素β-1a（利比）治疗多发性硬化症的血液学效应

Drug Saf. 2004;27(10):745-56. doi: 10.2165/00002018-200427100-00005.

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.联合使用β-干扰素和阿托伐他汀可能会增加多发性硬化症的疾病活动度。

Neurology. 2009 Sep 29;73(13):1078; author reply 1078-9. doi: 10.1212/WNL.0b013e3181ab6e08.

Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis.多发性硬化症患者接受肌肉内注射干扰素 β-1a 治疗后出现广泛荨麻疹。

Neurol Sci. 2011 Apr;32(2):309-11. doi: 10.1007/s10072-010-0432-0. Epub 2010 Oct 2.

[The use of rebif in the Moscow Municipal Multiple Sclerosis Center].[莫斯科市多发性硬化症中心对利比的使用情况]

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2 Pt 2):68-71.

Subcutaneous recombinant interferon-beta-1a (Rebif): a review of its use in relapsing-remitting multiple sclerosis.皮下注射重组干扰素β-1a（利比）：其在复发缓解型多发性硬化症中的应用综述

Drugs. 2005;65(9):1295-312. doi: 10.2165/00003495-200565090-00010.

A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis.一项关于复发缓解型多发性硬化症患者中，通过自动注射或手动注射给予干扰素β-1a（Rebif）的耐受性的随机、多中心、开放标签、平行组试验。

Mult Scler. 2005 Oct;11(5):585-91. doi: 10.1191/1352458505ms1197oa.

[PRISMS study. Interferon beta-1a therapy in relapsing-remitting multiple sclerosis].[PRISMS研究。复发缓解型多发性硬化症的干扰素β-1a治疗]

Internist (Berl). 2001 Feb;42(2):305-7. doi: 10.1007/s001080050753.

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.阿仑单抗与干扰素β1a 作为复发缓解型多发性硬化症一线治疗的比较：一项随机对照 3 期试验。

Lancet. 2012 Nov 24;380(9856):1819-28. doi: 10.1016/S0140-6736(12)61769-3. Epub 2012 Nov 1.

引用本文的文献

Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports.醋酸格拉替雷和干扰素β-1a治疗多发性硬化症患者的不良副作用：病例报告的系统评价

Curr J Neurol. 2023 Apr 4;22(2):115-136. doi: 10.18502/cjn.v22i2.13340.

Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications.精神科药物不良反应以及潜在的抗 COVID-19 药物与精神药物的相互作用。

Iran J Pharm Res. 2021 Summer;20(3):66-77. doi: 10.22037/ijpr.2021.114717.15007.

(+)-Naloxone blocks Toll-like receptor 4 to ameliorate deleterious effects of stress on male mouse behaviors.（+）-纳洛酮通过阻断 Toll 样受体 4 减轻应激对雄性小鼠行为的有害影响。

Brain Behav Immun. 2020 Nov;90:226-234. doi: 10.1016/j.bbi.2020.08.022. Epub 2020 Aug 26.

An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists.多发性硬化症聚乙二醇干扰素β-1a 管理的最新进展：德国和奥地利神经科医生与皮肤科医生跨学科委员会的研究结果。

BMC Neurol. 2019 Jun 15;19(1):130. doi: 10.1186/s12883-019-1354-y.

Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis.探讨小胶质细胞在与实验性多发性硬化症相关的心境障碍中的作用。

Front Cell Neurosci. 2015 Jun 25;9:243. doi: 10.3389/fncel.2015.00243. eCollection 2015.

Melatonin acts as antioxidant and improves sleep in MS patients.褪黑素具有抗氧化作用，并能改善多发性硬化症患者的睡眠。

Neurochem Res. 2014 Aug;39(8):1585-93. doi: 10.1007/s11064-014-1347-6. Epub 2014 Jun 30.

Relationship between disease-modifying therapy and depression in multiple sclerosis.多发性硬化症中疾病修饰疗法与抑郁症之间的关系。

Int J MS Care. 2013 Fall;15(3):107-12. doi: 10.7224/1537-2073.2012-036.

Gene expression profiling in postmortem prefrontal cortex of major depressive disorder.重度抑郁症患者死后前额叶皮层的基因表达谱分析

J Neurosci. 2007 Nov 28;27(48):13329-40. doi: 10.1523/JNEUROSCI.4083-07.2007.

Depression in multiple sclerosis: a review.多发性硬化症中的抑郁：综述

J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):469-75. doi: 10.1136/jnnp.2004.054635.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验